Clinical trial
Efficacy of Vedolizumab in Crohn's Disease Patients Naive to Biological Therapy: a Brazilian Multicentric Observational Real-world Study
NCT04362735 is registered in ClinicalTrials.gov with Pontifícia Universidade Católica do Paraná as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Vedolizumab in Crohn's Disease Patients Naive to Biological Therapy: a Brazilian Multicentric Observational Real-world Study
- Lead sponsor
- Pontifícia Universidade Católica do Paraná
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 1, 2020
- Completion date
- April 1, 2021
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.